Institutional members access full text with Ovid®

Share this article on:

Labeling Changes Promoting Safe Use of Long-Acting Opioids

Aschenbrenner, Diane S. MS, RN

AJN The American Journal of Nursing: January 2014 - Volume 114 - Issue 1 - p 24,25
doi: 10.1097/01.NAJ.0000441788.62785.29
Drug Watch
  • The labeling of extended-release and long-acting opioid analgesics has been revised to warn practitioners that the drugs have been associated with misuse, abuse, life-threatening respiratory depression, accidental exposure, neonatal opioid withdrawal syndrome, and (with some drugs) serious drug interactions with alcohol.
  • The labeling will also state that long-acting opioids should only be used if other pain relief methods aren't effective.

Diane S. Aschenbrenner recently retired as course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: daschen1@jhu.edu.

© 2014 Lippincott Williams & Wilkins. All rights reserved.